Clinical Trials
2 trialsNCT06202599 2024-01-17
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
Peking University People's Hospital
Completed
NCT01645215 2020-02-17
Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors
Hutchmed
Phase 1 Completed